Molecular Oncology: Underlying Mechanisms
and Translational Advancements

dc.contributor.author	Farooqi, Ammad Ahmad
dc.contributor.author	Nabavi, Seyed Mohammad
dc.contributor.author	Purenovic, Jelena
dc.contributor.author	İsmail, Muhammad
dc.contributor.author	YAYLIM, İlhan
dc.contributor.author	Sobczak-Kupiec, Agnieszka
dc.contributor.author	Javed Iqbal, Muhammad
dc.contributor.author	Zahid Qureshi, Muhammad
dc.contributor.author	Mansoor, Qaisar
dc.date.accessioned	2021-03-03T15:50:16Z
dc.date.available	2021-03-03T15:50:16Z
dc.identifier.citation	YAYLIM İ., Sobczak-Kupiec A., Javed Iqbal ., Zahid Qureshi M., Mansoor ., Nabavi S. M. , Purenovic J., Farooqi A. A. , İsmail M., Role of TRAIL and miR-34a as Therapeutic Agents in Prostate Cancer: Increasing the Armory of Micro-Musketeers, "Molecular Oncology: Underlying Mechanisms and Translational Advancements", Farooqi AA, İsmail M, Editör, Springer, London/Berlin , Gewerbestrasse, ss.293-300, 2018
dc.identifier.other	vv_1032021
dc.identifier.other	av_41150406-817b-4221-88ab-093768e92a23
dc.identifier.uri	http://hdl.handle.net/20.500.12627/47480
dc.language.iso	eng
dc.publisher	Springer, London/Berlin
dc.title	Molecular Oncology: Underlying Mechanisms and Translational Advancements
dc.type	Kitapta Bölüm
dc.contributor.department	, ,
dc.contributor.firstauthorID	653587

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.